Cargando…
A double‐blind, placebo‐controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss
Mirtazapine is classified as a weight gain drug in cats, and the purpose of this study was to evaluate its efficacy in cats experiencing unintended weight loss. This was a multi‐center, double‐blind, placebo‐controlled, randomized clinical study in client‐owned cats ≥1 year of age, weighing ≥2 kg, w...
Autores principales: | Poole, Melinda, Quimby, Jessica M., Hu, Tianhua, Labelle, Daizie, Buhles, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379659/ https://www.ncbi.nlm.nih.gov/pubmed/30506924 http://dx.doi.org/10.1111/jvp.12738 |
Ejemplares similares
-
Assessment of compounded transdermal mirtazapine as an appetite
stimulant in cats with chronic kidney disease
por: Quimby, Jessica M, et al.
Publicado: (2019) -
Appetite Stimulant and Anti-Emetic Effect of Mirtazapine Transdermal Ointment in Cats Affected by Lymphoma Following Chemotherapy Administration: A Multi-Centre Retrospective Study
por: Ferro, Livia, et al.
Publicado: (2022) -
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men
por: Lechner, Katharina, et al.
Publicado: (2023) -
In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease
por: Fitzpatrick, Rikki L., et al.
Publicado: (2018) -
POOR POSTNATAL WEIGHT GAIN AS A PREDICTOR OF RETINOPATHY OF PREMATURITY
por: Behin Šarić, Ivana, et al.
Publicado: (2020)